Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Trimegah Karya Pratama Tbk. (UVCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Trimegah Karya Pratama Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp143 (market cap 292.02B, 10.68M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Trimegah Karya Pratama Tbk. are close in size by market cap, and Trimegah Karya Pratama Tbk. is more actively traded (10.68M versus 7.6K). Which is the better fit depends on your goals.
| DGNS | UVCR | |
|---|---|---|
Market Cap | 319B | 292.02B |
Volume | 7.6K | 10.68M |
Lot | 76 | 106.82K |
Turnover | 1.74M | 1.54B |
Average Price | 229.21 | 144.06 |
Value | 1.74M | 1.54B |
Indicative Equilibrium Price | 232 | 146 |
Indicative Equilibrium Volume | 200 | 117.3K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Trimegah Karya Pratama Tbk.
PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Read more on UVCR →
